Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
Syros Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 28, 2020
Syros Pharmaceuticals reported fiscal year 2019 executive compensation information on April 28, 2020.
In 2019, three executives at Syros Pharmaceuticals received on average a compensation package of $2.3M, a 17% increase compared to previous year.
Average pay of disclosed executives at Syros Pharmaceuticals
Nancy Simonian, Chief Executive Officer, received $3.6M in total, which increased by 19% compared to 2018. 40% of Simonian's compensation, or $1.5M, was in option awards. Simonian also received $319K in non-equity incentive plan, $578K in salary, $1.3M in stock awards, as well as $360 in other compensation.
David A. Roth, Chief Medical Officer, received a compensation package of $1.6M, which increased by 35% compared to previous year. 36% of the compensation package, or $584K, was in stock awards.
Eric R. Olson, Chief Scientific Officer, earned $1.6M in 2019, a 35% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 28, 2020.